nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Progesterone—uterine cancer	0.212	0.32	CbGbCtD
Zoledronate—ABCC1—Dactinomycin—uterine cancer	0.168	0.254	CbGbCtD
Zoledronate—ABCC1—Epirubicin—uterine cancer	0.122	0.184	CbGbCtD
Zoledronate—ABCC1—Etoposide—uterine cancer	0.095	0.143	CbGbCtD
Zoledronate—ABCC1—Doxorubicin—uterine cancer	0.0648	0.0978	CbGbCtD
Zoledronate—GGPS1—myometrium—uterine cancer	0.00701	0.0669	CbGeAlD
Zoledronate—GGPS1—uterine cervix—uterine cancer	0.00545	0.052	CbGeAlD
Zoledronate—GGPS1—decidua—uterine cancer	0.00519	0.0496	CbGeAlD
Zoledronate—GGPS1—renal system—uterine cancer	0.0051	0.0487	CbGeAlD
Zoledronate—GGPS1—endometrium—uterine cancer	0.00493	0.0471	CbGeAlD
Zoledronate—GGPS1—mammalian vulva—uterine cancer	0.00477	0.0455	CbGeAlD
Zoledronate—GGPS1—uterus—uterine cancer	0.00454	0.0434	CbGeAlD
Zoledronate—GGPS1—female reproductive system—uterine cancer	0.00409	0.039	CbGeAlD
Zoledronate—GGPS1—female gonad—uterine cancer	0.00372	0.0355	CbGeAlD
Zoledronate—GGPS1—vagina—uterine cancer	0.00369	0.0353	CbGeAlD
Zoledronate—FDPS—myometrium—uterine cancer	0.00323	0.0308	CbGeAlD
Zoledronate—CA2—exocrine gland—uterine cancer	0.00303	0.0289	CbGeAlD
Zoledronate—FDPS—uterine cervix—uterine cancer	0.00251	0.024	CbGeAlD
Zoledronate—FDPS—smooth muscle tissue—uterine cancer	0.00244	0.0233	CbGeAlD
Zoledronate—FDPS—decidua—uterine cancer	0.00239	0.0229	CbGeAlD
Zoledronate—GGPS1—lymph node—uterine cancer	0.00239	0.0228	CbGeAlD
Zoledronate—CA12—renal system—uterine cancer	0.00238	0.0227	CbGeAlD
Zoledronate—FDPS—renal system—uterine cancer	0.00235	0.0224	CbGeAlD
Zoledronate—FDPS—endometrium—uterine cancer	0.00227	0.0217	CbGeAlD
Zoledronate—FDPS—mammalian vulva—uterine cancer	0.0022	0.021	CbGeAlD
Zoledronate—FDPS—uterus—uterine cancer	0.00209	0.02	CbGeAlD
Zoledronate—CA12—female reproductive system—uterine cancer	0.0019	0.0182	CbGeAlD
Zoledronate—FDPS—female reproductive system—uterine cancer	0.00188	0.018	CbGeAlD
Zoledronate—ABCC1—myometrium—uterine cancer	0.00188	0.0179	CbGeAlD
Zoledronate—FDPS—female gonad—uterine cancer	0.00171	0.0164	CbGeAlD
Zoledronate—FDPS—vagina—uterine cancer	0.0017	0.0163	CbGeAlD
Zoledronate—ABCC1—uterine cervix—uterine cancer	0.00146	0.0139	CbGeAlD
Zoledronate—ABCC1—decidua—uterine cancer	0.00139	0.0133	CbGeAlD
Zoledronate—ABCC1—endometrium—uterine cancer	0.00132	0.0126	CbGeAlD
Zoledronate—CA2—epithelium—uterine cancer	0.00132	0.0126	CbGeAlD
Zoledronate—ABCC1—mammalian vulva—uterine cancer	0.00128	0.0122	CbGeAlD
Zoledronate—CA2—smooth muscle tissue—uterine cancer	0.00127	0.0121	CbGeAlD
Zoledronate—CA2—decidua—uterine cancer	0.00124	0.0119	CbGeAlD
Zoledronate—CA2—renal system—uterine cancer	0.00122	0.0117	CbGeAlD
Zoledronate—ABCC1—uterus—uterine cancer	0.00122	0.0116	CbGeAlD
Zoledronate—CA2—mammalian vulva—uterine cancer	0.00114	0.0109	CbGeAlD
Zoledronate—FDPS—lymph node—uterine cancer	0.0011	0.0105	CbGeAlD
Zoledronate—ABCC1—female gonad—uterine cancer	0.000995	0.0095	CbGeAlD
Zoledronate—ABCC1—vagina—uterine cancer	0.000989	0.00944	CbGeAlD
Zoledronate—CA2—female reproductive system—uterine cancer	0.000978	0.00933	CbGeAlD
Zoledronate—CA2—female gonad—uterine cancer	0.00089	0.00849	CbGeAlD
Zoledronate—CA2—vagina—uterine cancer	0.000884	0.00844	CbGeAlD
Zoledronate—ABCC1—lymph node—uterine cancer	0.00064	0.00611	CbGeAlD
Zoledronate—CA2—lymph node—uterine cancer	0.000572	0.00546	CbGeAlD
Zoledronate—Osteoarthritis—Doxorubicin—uterine cancer	0.000215	0.000924	CcSEcCtD
Zoledronate—Pain in extremity—Doxorubicin—uterine cancer	0.000215	0.000924	CcSEcCtD
Zoledronate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000215	0.000921	CcSEcCtD
Zoledronate—Chest pain—Etoposide—uterine cancer	0.000213	0.000914	CcSEcCtD
Zoledronate—Abdominal pain upper—Epirubicin—uterine cancer	0.000213	0.000912	CcSEcCtD
Zoledronate—Hypokalaemia—Epirubicin—uterine cancer	0.000212	0.000909	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000211	0.000907	CcSEcCtD
Zoledronate—Discomfort—Etoposide—uterine cancer	0.00021	0.000903	CcSEcCtD
Zoledronate—Nasopharyngitis—Epirubicin—uterine cancer	0.000208	0.000893	CcSEcCtD
Zoledronate—Hypersensitivity—Dactinomycin—uterine cancer	0.000208	0.000891	CcSEcCtD
Zoledronate—Gastritis—Epirubicin—uterine cancer	0.000206	0.000884	CcSEcCtD
Zoledronate—Confusional state—Etoposide—uterine cancer	0.000206	0.000883	CcSEcCtD
Zoledronate—Muscular weakness—Epirubicin—uterine cancer	0.000205	0.000881	CcSEcCtD
Zoledronate—Anaphylactic shock—Etoposide—uterine cancer	0.000204	0.000876	CcSEcCtD
Zoledronate—Infection—Etoposide—uterine cancer	0.000203	0.00087	CcSEcCtD
Zoledronate—Abdominal distension—Epirubicin—uterine cancer	0.000203	0.000869	CcSEcCtD
Zoledronate—Asthenia—Dactinomycin—uterine cancer	0.000202	0.000868	CcSEcCtD
Zoledronate—Blood creatinine increased—Doxorubicin—uterine cancer	0.000202	0.000866	CcSEcCtD
Zoledronate—Dysphagia—Epirubicin—uterine cancer	0.000201	0.000863	CcSEcCtD
Zoledronate—Asthma—Epirubicin—uterine cancer	0.000201	0.000863	CcSEcCtD
Zoledronate—Influenza—Epirubicin—uterine cancer	0.000201	0.000863	CcSEcCtD
Zoledronate—Dehydration—Doxorubicin—uterine cancer	0.0002	0.000859	CcSEcCtD
Zoledronate—Thrombocytopenia—Etoposide—uterine cancer	0.0002	0.000857	CcSEcCtD
Zoledronate—Tachycardia—Etoposide—uterine cancer	0.000199	0.000855	CcSEcCtD
Zoledronate—Skin disorder—Etoposide—uterine cancer	0.000198	0.000851	CcSEcCtD
Zoledronate—Hyperhidrosis—Etoposide—uterine cancer	0.000197	0.000847	CcSEcCtD
Zoledronate—Abdominal pain upper—Doxorubicin—uterine cancer	0.000197	0.000844	CcSEcCtD
Zoledronate—Hypokalaemia—Doxorubicin—uterine cancer	0.000196	0.000841	CcSEcCtD
Zoledronate—Anorexia—Etoposide—uterine cancer	0.000195	0.000835	CcSEcCtD
Zoledronate—Diarrhoea—Dactinomycin—uterine cancer	0.000193	0.000828	CcSEcCtD
Zoledronate—Nasopharyngitis—Doxorubicin—uterine cancer	0.000193	0.000826	CcSEcCtD
Zoledronate—Pancytopenia—Epirubicin—uterine cancer	0.000191	0.00082	CcSEcCtD
Zoledronate—Hypotension—Etoposide—uterine cancer	0.000191	0.000818	CcSEcCtD
Zoledronate—Gastritis—Doxorubicin—uterine cancer	0.000191	0.000818	CcSEcCtD
Zoledronate—Muscular weakness—Doxorubicin—uterine cancer	0.00019	0.000815	CcSEcCtD
Zoledronate—Neutropenia—Epirubicin—uterine cancer	0.000188	0.000807	CcSEcCtD
Zoledronate—Abdominal distension—Doxorubicin—uterine cancer	0.000187	0.000804	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000187	0.000802	CcSEcCtD
Zoledronate—Influenza—Doxorubicin—uterine cancer	0.000186	0.000799	CcSEcCtD
Zoledronate—Asthma—Doxorubicin—uterine cancer	0.000186	0.000799	CcSEcCtD
Zoledronate—Dysphagia—Doxorubicin—uterine cancer	0.000186	0.000799	CcSEcCtD
Zoledronate—Pollakiuria—Epirubicin—uterine cancer	0.000186	0.000797	CcSEcCtD
Zoledronate—Paraesthesia—Etoposide—uterine cancer	0.000183	0.000786	CcSEcCtD
Zoledronate—Weight increased—Epirubicin—uterine cancer	0.000183	0.000786	CcSEcCtD
Zoledronate—Weight decreased—Epirubicin—uterine cancer	0.000182	0.000781	CcSEcCtD
Zoledronate—Dyspnoea—Etoposide—uterine cancer	0.000182	0.000781	CcSEcCtD
Zoledronate—Somnolence—Etoposide—uterine cancer	0.000181	0.000779	CcSEcCtD
Zoledronate—Infestation NOS—Epirubicin—uterine cancer	0.000179	0.00077	CcSEcCtD
Zoledronate—Infestation—Epirubicin—uterine cancer	0.000179	0.00077	CcSEcCtD
Zoledronate—Vomiting—Dactinomycin—uterine cancer	0.000179	0.000769	CcSEcCtD
Zoledronate—Rash—Dactinomycin—uterine cancer	0.000178	0.000763	CcSEcCtD
Zoledronate—Decreased appetite—Etoposide—uterine cancer	0.000177	0.000761	CcSEcCtD
Zoledronate—Pancytopenia—Doxorubicin—uterine cancer	0.000177	0.000759	CcSEcCtD
Zoledronate—Renal failure—Epirubicin—uterine cancer	0.000176	0.000757	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Etoposide—uterine cancer	0.000176	0.000756	CcSEcCtD
Zoledronate—Fatigue—Etoposide—uterine cancer	0.000176	0.000755	CcSEcCtD
Zoledronate—Stomatitis—Epirubicin—uterine cancer	0.000175	0.00075	CcSEcCtD
Zoledronate—Constipation—Etoposide—uterine cancer	0.000175	0.000749	CcSEcCtD
Zoledronate—Pain—Etoposide—uterine cancer	0.000175	0.000749	CcSEcCtD
Zoledronate—Urinary tract infection—Epirubicin—uterine cancer	0.000174	0.000748	CcSEcCtD
Zoledronate—Conjunctivitis—Epirubicin—uterine cancer	0.000174	0.000748	CcSEcCtD
Zoledronate—Neutropenia—Doxorubicin—uterine cancer	0.000174	0.000747	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000173	0.000742	CcSEcCtD
Zoledronate—Pollakiuria—Doxorubicin—uterine cancer	0.000172	0.000738	CcSEcCtD
Zoledronate—Haematuria—Epirubicin—uterine cancer	0.000171	0.000734	CcSEcCtD
Zoledronate—Weight increased—Doxorubicin—uterine cancer	0.000169	0.000727	CcSEcCtD
Zoledronate—Weight decreased—Doxorubicin—uterine cancer	0.000168	0.000723	CcSEcCtD
Zoledronate—Feeling abnormal—Etoposide—uterine cancer	0.000168	0.000722	CcSEcCtD
Zoledronate—Nausea—Dactinomycin—uterine cancer	0.000167	0.000719	CcSEcCtD
Zoledronate—Agranulocytosis—Epirubicin—uterine cancer	0.000167	0.000718	CcSEcCtD
Zoledronate—Gastrointestinal pain—Etoposide—uterine cancer	0.000167	0.000716	CcSEcCtD
Zoledronate—Infestation NOS—Doxorubicin—uterine cancer	0.000166	0.000712	CcSEcCtD
Zoledronate—Infestation—Doxorubicin—uterine cancer	0.000166	0.000712	CcSEcCtD
Zoledronate—Bradycardia—Epirubicin—uterine cancer	0.000164	0.000703	CcSEcCtD
Zoledronate—Renal failure—Doxorubicin—uterine cancer	0.000163	0.0007	CcSEcCtD
Zoledronate—Urticaria—Etoposide—uterine cancer	0.000162	0.000696	CcSEcCtD
Zoledronate—Stomatitis—Doxorubicin—uterine cancer	0.000162	0.000694	CcSEcCtD
Zoledronate—Body temperature increased—Etoposide—uterine cancer	0.000161	0.000692	CcSEcCtD
Zoledronate—Abdominal pain—Etoposide—uterine cancer	0.000161	0.000692	CcSEcCtD
Zoledronate—Urinary tract infection—Doxorubicin—uterine cancer	0.000161	0.000692	CcSEcCtD
Zoledronate—Conjunctivitis—Doxorubicin—uterine cancer	0.000161	0.000692	CcSEcCtD
Zoledronate—Hypoaesthesia—Epirubicin—uterine cancer	0.00016	0.000687	CcSEcCtD
Zoledronate—Urinary tract disorder—Epirubicin—uterine cancer	0.000159	0.000682	CcSEcCtD
Zoledronate—Oedema peripheral—Epirubicin—uterine cancer	0.000159	0.000681	CcSEcCtD
Zoledronate—Haematuria—Doxorubicin—uterine cancer	0.000158	0.000679	CcSEcCtD
Zoledronate—Connective tissue disorder—Epirubicin—uterine cancer	0.000158	0.000679	CcSEcCtD
Zoledronate—Urethral disorder—Epirubicin—uterine cancer	0.000158	0.000677	CcSEcCtD
Zoledronate—Agranulocytosis—Doxorubicin—uterine cancer	0.000155	0.000665	CcSEcCtD
Zoledronate—Bradycardia—Doxorubicin—uterine cancer	0.000152	0.000651	CcSEcCtD
Zoledronate—Eye disorder—Epirubicin—uterine cancer	0.00015	0.000646	CcSEcCtD
Zoledronate—Hypersensitivity—Etoposide—uterine cancer	0.00015	0.000645	CcSEcCtD
Zoledronate—Flushing—Epirubicin—uterine cancer	0.000149	0.000641	CcSEcCtD
Zoledronate—Cardiac disorder—Epirubicin—uterine cancer	0.000149	0.000641	CcSEcCtD
Zoledronate—Hypoaesthesia—Doxorubicin—uterine cancer	0.000148	0.000636	CcSEcCtD
Zoledronate—Urinary tract disorder—Doxorubicin—uterine cancer	0.000147	0.000631	CcSEcCtD
Zoledronate—Oedema peripheral—Doxorubicin—uterine cancer	0.000147	0.00063	CcSEcCtD
Zoledronate—Asthenia—Etoposide—uterine cancer	0.000146	0.000628	CcSEcCtD
Zoledronate—Connective tissue disorder—Doxorubicin—uterine cancer	0.000146	0.000628	CcSEcCtD
Zoledronate—Angiopathy—Epirubicin—uterine cancer	0.000146	0.000627	CcSEcCtD
Zoledronate—Urethral disorder—Doxorubicin—uterine cancer	0.000146	0.000627	CcSEcCtD
Zoledronate—Immune system disorder—Epirubicin—uterine cancer	0.000145	0.000624	CcSEcCtD
Zoledronate—Mediastinal disorder—Epirubicin—uterine cancer	0.000145	0.000623	CcSEcCtD
Zoledronate—Chills—Epirubicin—uterine cancer	0.000144	0.00062	CcSEcCtD
Zoledronate—Pruritus—Etoposide—uterine cancer	0.000144	0.00062	CcSEcCtD
Zoledronate—Arrhythmia—Epirubicin—uterine cancer	0.000144	0.000617	CcSEcCtD
Zoledronate—Alopecia—Epirubicin—uterine cancer	0.000142	0.000611	CcSEcCtD
Zoledronate—Mental disorder—Epirubicin—uterine cancer	0.000141	0.000605	CcSEcCtD
Zoledronate—Erythema—Epirubicin—uterine cancer	0.00014	0.000601	CcSEcCtD
Zoledronate—Malnutrition—Epirubicin—uterine cancer	0.00014	0.000601	CcSEcCtD
Zoledronate—Diarrhoea—Etoposide—uterine cancer	0.00014	0.000599	CcSEcCtD
Zoledronate—Eye disorder—Doxorubicin—uterine cancer	0.000139	0.000597	CcSEcCtD
Zoledronate—Cardiac disorder—Doxorubicin—uterine cancer	0.000138	0.000593	CcSEcCtD
Zoledronate—Flushing—Doxorubicin—uterine cancer	0.000138	0.000593	CcSEcCtD
Zoledronate—Dysgeusia—Epirubicin—uterine cancer	0.000137	0.000589	CcSEcCtD
Zoledronate—Back pain—Epirubicin—uterine cancer	0.000136	0.000582	CcSEcCtD
Zoledronate—Angiopathy—Doxorubicin—uterine cancer	0.000135	0.00058	CcSEcCtD
Zoledronate—Dizziness—Etoposide—uterine cancer	0.000135	0.000579	CcSEcCtD
Zoledronate—Muscle spasms—Epirubicin—uterine cancer	0.000135	0.000578	CcSEcCtD
Zoledronate—Immune system disorder—Doxorubicin—uterine cancer	0.000135	0.000577	CcSEcCtD
Zoledronate—Mediastinal disorder—Doxorubicin—uterine cancer	0.000134	0.000576	CcSEcCtD
Zoledronate—Chills—Doxorubicin—uterine cancer	0.000134	0.000574	CcSEcCtD
Zoledronate—Arrhythmia—Doxorubicin—uterine cancer	0.000133	0.000571	CcSEcCtD
Zoledronate—Vision blurred—Epirubicin—uterine cancer	0.000132	0.000567	CcSEcCtD
Zoledronate—Alopecia—Doxorubicin—uterine cancer	0.000132	0.000565	CcSEcCtD
Zoledronate—Mental disorder—Doxorubicin—uterine cancer	0.000131	0.00056	CcSEcCtD
Zoledronate—Ill-defined disorder—Epirubicin—uterine cancer	0.00013	0.000558	CcSEcCtD
Zoledronate—Vomiting—Etoposide—uterine cancer	0.00013	0.000557	CcSEcCtD
Zoledronate—Erythema—Doxorubicin—uterine cancer	0.00013	0.000557	CcSEcCtD
Zoledronate—Malnutrition—Doxorubicin—uterine cancer	0.00013	0.000557	CcSEcCtD
Zoledronate—Anaemia—Epirubicin—uterine cancer	0.00013	0.000556	CcSEcCtD
Zoledronate—Agitation—Epirubicin—uterine cancer	0.000129	0.000553	CcSEcCtD
Zoledronate—Rash—Etoposide—uterine cancer	0.000129	0.000552	CcSEcCtD
Zoledronate—Dermatitis—Etoposide—uterine cancer	0.000129	0.000552	CcSEcCtD
Zoledronate—Headache—Etoposide—uterine cancer	0.000128	0.000549	CcSEcCtD
Zoledronate—Dysgeusia—Doxorubicin—uterine cancer	0.000127	0.000545	CcSEcCtD
Zoledronate—Malaise—Epirubicin—uterine cancer	0.000126	0.000542	CcSEcCtD
Zoledronate—Vertigo—Epirubicin—uterine cancer	0.000126	0.00054	CcSEcCtD
Zoledronate—Syncope—Epirubicin—uterine cancer	0.000126	0.000539	CcSEcCtD
Zoledronate—Leukopenia—Epirubicin—uterine cancer	0.000125	0.000538	CcSEcCtD
Zoledronate—Back pain—Doxorubicin—uterine cancer	0.000125	0.000538	CcSEcCtD
Zoledronate—Muscle spasms—Doxorubicin—uterine cancer	0.000125	0.000535	CcSEcCtD
Zoledronate—Palpitations—Epirubicin—uterine cancer	0.000124	0.000532	CcSEcCtD
Zoledronate—Loss of consciousness—Epirubicin—uterine cancer	0.000123	0.000529	CcSEcCtD
Zoledronate—Cough—Epirubicin—uterine cancer	0.000122	0.000525	CcSEcCtD
Zoledronate—Vision blurred—Doxorubicin—uterine cancer	0.000122	0.000525	CcSEcCtD
Zoledronate—Convulsion—Epirubicin—uterine cancer	0.000121	0.000521	CcSEcCtD
Zoledronate—Nausea—Etoposide—uterine cancer	0.000121	0.00052	CcSEcCtD
Zoledronate—Hypertension—Epirubicin—uterine cancer	0.000121	0.000519	CcSEcCtD
Zoledronate—Ill-defined disorder—Doxorubicin—uterine cancer	0.00012	0.000516	CcSEcCtD
Zoledronate—Anaemia—Doxorubicin—uterine cancer	0.00012	0.000514	CcSEcCtD
Zoledronate—Myalgia—Epirubicin—uterine cancer	0.000119	0.000512	CcSEcCtD
Zoledronate—Chest pain—Epirubicin—uterine cancer	0.000119	0.000512	CcSEcCtD
Zoledronate—Arthralgia—Epirubicin—uterine cancer	0.000119	0.000512	CcSEcCtD
Zoledronate—Agitation—Doxorubicin—uterine cancer	0.000119	0.000511	CcSEcCtD
Zoledronate—Anxiety—Epirubicin—uterine cancer	0.000119	0.00051	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000119	0.000509	CcSEcCtD
Zoledronate—Discomfort—Epirubicin—uterine cancer	0.000118	0.000506	CcSEcCtD
Zoledronate—Malaise—Doxorubicin—uterine cancer	0.000117	0.000502	CcSEcCtD
Zoledronate—Dry mouth—Epirubicin—uterine cancer	0.000117	0.000501	CcSEcCtD
Zoledronate—Vertigo—Doxorubicin—uterine cancer	0.000117	0.0005	CcSEcCtD
Zoledronate—Syncope—Doxorubicin—uterine cancer	0.000116	0.000499	CcSEcCtD
Zoledronate—Leukopenia—Doxorubicin—uterine cancer	0.000116	0.000498	CcSEcCtD
Zoledronate—Confusional state—Epirubicin—uterine cancer	0.000115	0.000495	CcSEcCtD
Zoledronate—Palpitations—Doxorubicin—uterine cancer	0.000115	0.000492	CcSEcCtD
Zoledronate—Anaphylactic shock—Epirubicin—uterine cancer	0.000114	0.000491	CcSEcCtD
Zoledronate—Oedema—Epirubicin—uterine cancer	0.000114	0.000491	CcSEcCtD
Zoledronate—Loss of consciousness—Doxorubicin—uterine cancer	0.000114	0.000489	CcSEcCtD
Zoledronate—Infection—Epirubicin—uterine cancer	0.000114	0.000488	CcSEcCtD
Zoledronate—Cough—Doxorubicin—uterine cancer	0.000113	0.000486	CcSEcCtD
Zoledronate—Shock—Epirubicin—uterine cancer	0.000113	0.000483	CcSEcCtD
Zoledronate—Convulsion—Doxorubicin—uterine cancer	0.000112	0.000482	CcSEcCtD
Zoledronate—Nervous system disorder—Epirubicin—uterine cancer	0.000112	0.000481	CcSEcCtD
Zoledronate—Thrombocytopenia—Epirubicin—uterine cancer	0.000112	0.000481	CcSEcCtD
Zoledronate—Hypertension—Doxorubicin—uterine cancer	0.000112	0.00048	CcSEcCtD
Zoledronate—Tachycardia—Epirubicin—uterine cancer	0.000112	0.000479	CcSEcCtD
Zoledronate—Skin disorder—Epirubicin—uterine cancer	0.000111	0.000477	CcSEcCtD
Zoledronate—Hyperhidrosis—Epirubicin—uterine cancer	0.000111	0.000475	CcSEcCtD
Zoledronate—Myalgia—Doxorubicin—uterine cancer	0.00011	0.000474	CcSEcCtD
Zoledronate—Chest pain—Doxorubicin—uterine cancer	0.00011	0.000474	CcSEcCtD
Zoledronate—Arthralgia—Doxorubicin—uterine cancer	0.00011	0.000474	CcSEcCtD
Zoledronate—Anxiety—Doxorubicin—uterine cancer	0.00011	0.000472	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00011	0.000471	CcSEcCtD
Zoledronate—Discomfort—Doxorubicin—uterine cancer	0.000109	0.000468	CcSEcCtD
Zoledronate—Anorexia—Epirubicin—uterine cancer	0.000109	0.000468	CcSEcCtD
Zoledronate—Dry mouth—Doxorubicin—uterine cancer	0.000108	0.000463	CcSEcCtD
Zoledronate—Hypotension—Epirubicin—uterine cancer	0.000107	0.000459	CcSEcCtD
Zoledronate—Confusional state—Doxorubicin—uterine cancer	0.000107	0.000458	CcSEcCtD
Zoledronate—Oedema—Doxorubicin—uterine cancer	0.000106	0.000454	CcSEcCtD
Zoledronate—Anaphylactic shock—Doxorubicin—uterine cancer	0.000106	0.000454	CcSEcCtD
Zoledronate—Infection—Doxorubicin—uterine cancer	0.000105	0.000451	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000104	0.000447	CcSEcCtD
Zoledronate—Shock—Doxorubicin—uterine cancer	0.000104	0.000447	CcSEcCtD
Zoledronate—Nervous system disorder—Doxorubicin—uterine cancer	0.000104	0.000445	CcSEcCtD
Zoledronate—Thrombocytopenia—Doxorubicin—uterine cancer	0.000104	0.000445	CcSEcCtD
Zoledronate—Insomnia—Epirubicin—uterine cancer	0.000103	0.000444	CcSEcCtD
Zoledronate—Tachycardia—Doxorubicin—uterine cancer	0.000103	0.000443	CcSEcCtD
Zoledronate—Skin disorder—Doxorubicin—uterine cancer	0.000103	0.000441	CcSEcCtD
Zoledronate—Paraesthesia—Epirubicin—uterine cancer	0.000103	0.000441	CcSEcCtD
Zoledronate—Hyperhidrosis—Doxorubicin—uterine cancer	0.000102	0.000439	CcSEcCtD
Zoledronate—Dyspnoea—Epirubicin—uterine cancer	0.000102	0.000438	CcSEcCtD
Zoledronate—Somnolence—Epirubicin—uterine cancer	0.000102	0.000436	CcSEcCtD
Zoledronate—Anorexia—Doxorubicin—uterine cancer	0.000101	0.000433	CcSEcCtD
Zoledronate—Dyspepsia—Epirubicin—uterine cancer	0.000101	0.000432	CcSEcCtD
Zoledronate—Decreased appetite—Epirubicin—uterine cancer	9.94e-05	0.000427	CcSEcCtD
Zoledronate—Hypotension—Doxorubicin—uterine cancer	9.89e-05	0.000424	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Epirubicin—uterine cancer	9.88e-05	0.000424	CcSEcCtD
Zoledronate—Fatigue—Epirubicin—uterine cancer	9.86e-05	0.000423	CcSEcCtD
Zoledronate—Pain—Epirubicin—uterine cancer	9.78e-05	0.00042	CcSEcCtD
Zoledronate—Constipation—Epirubicin—uterine cancer	9.78e-05	0.00042	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Doxorubicin—uterine cancer	9.64e-05	0.000414	CcSEcCtD
Zoledronate—Insomnia—Doxorubicin—uterine cancer	9.57e-05	0.000411	CcSEcCtD
Zoledronate—Paraesthesia—Doxorubicin—uterine cancer	9.5e-05	0.000408	CcSEcCtD
Zoledronate—Dyspnoea—Doxorubicin—uterine cancer	9.44e-05	0.000405	CcSEcCtD
Zoledronate—Feeling abnormal—Epirubicin—uterine cancer	9.43e-05	0.000405	CcSEcCtD
Zoledronate—Somnolence—Doxorubicin—uterine cancer	9.41e-05	0.000404	CcSEcCtD
Zoledronate—Gastrointestinal pain—Epirubicin—uterine cancer	9.35e-05	0.000401	CcSEcCtD
Zoledronate—Dyspepsia—Doxorubicin—uterine cancer	9.32e-05	0.0004	CcSEcCtD
Zoledronate—Decreased appetite—Doxorubicin—uterine cancer	9.2e-05	0.000395	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Doxorubicin—uterine cancer	9.14e-05	0.000392	CcSEcCtD
Zoledronate—Fatigue—Doxorubicin—uterine cancer	9.13e-05	0.000392	CcSEcCtD
Zoledronate—Urticaria—Epirubicin—uterine cancer	9.09e-05	0.00039	CcSEcCtD
Zoledronate—Pain—Doxorubicin—uterine cancer	9.05e-05	0.000388	CcSEcCtD
Zoledronate—Constipation—Doxorubicin—uterine cancer	9.05e-05	0.000388	CcSEcCtD
Zoledronate—Abdominal pain—Epirubicin—uterine cancer	9.04e-05	0.000388	CcSEcCtD
Zoledronate—Body temperature increased—Epirubicin—uterine cancer	9.04e-05	0.000388	CcSEcCtD
Zoledronate—Feeling abnormal—Doxorubicin—uterine cancer	8.72e-05	0.000374	CcSEcCtD
Zoledronate—Gastrointestinal pain—Doxorubicin—uterine cancer	8.66e-05	0.000371	CcSEcCtD
Zoledronate—Hypersensitivity—Epirubicin—uterine cancer	8.43e-05	0.000362	CcSEcCtD
Zoledronate—Urticaria—Doxorubicin—uterine cancer	8.41e-05	0.000361	CcSEcCtD
Zoledronate—Abdominal pain—Doxorubicin—uterine cancer	8.37e-05	0.000359	CcSEcCtD
Zoledronate—Body temperature increased—Doxorubicin—uterine cancer	8.37e-05	0.000359	CcSEcCtD
Zoledronate—Asthenia—Epirubicin—uterine cancer	8.21e-05	0.000352	CcSEcCtD
Zoledronate—Pruritus—Epirubicin—uterine cancer	8.09e-05	0.000347	CcSEcCtD
Zoledronate—Diarrhoea—Epirubicin—uterine cancer	7.83e-05	0.000336	CcSEcCtD
Zoledronate—Hypersensitivity—Doxorubicin—uterine cancer	7.8e-05	0.000335	CcSEcCtD
Zoledronate—Asthenia—Doxorubicin—uterine cancer	7.59e-05	0.000326	CcSEcCtD
Zoledronate—Dizziness—Epirubicin—uterine cancer	7.56e-05	0.000325	CcSEcCtD
Zoledronate—Pruritus—Doxorubicin—uterine cancer	7.49e-05	0.000321	CcSEcCtD
Zoledronate—Vomiting—Epirubicin—uterine cancer	7.27e-05	0.000312	CcSEcCtD
Zoledronate—Diarrhoea—Doxorubicin—uterine cancer	7.24e-05	0.000311	CcSEcCtD
Zoledronate—Rash—Epirubicin—uterine cancer	7.21e-05	0.00031	CcSEcCtD
Zoledronate—Dermatitis—Epirubicin—uterine cancer	7.21e-05	0.000309	CcSEcCtD
Zoledronate—Headache—Epirubicin—uterine cancer	7.17e-05	0.000308	CcSEcCtD
Zoledronate—Dizziness—Doxorubicin—uterine cancer	7e-05	0.0003	CcSEcCtD
Zoledronate—Nausea—Epirubicin—uterine cancer	6.79e-05	0.000292	CcSEcCtD
Zoledronate—Vomiting—Doxorubicin—uterine cancer	6.73e-05	0.000289	CcSEcCtD
Zoledronate—Rash—Doxorubicin—uterine cancer	6.67e-05	0.000286	CcSEcCtD
Zoledronate—Dermatitis—Doxorubicin—uterine cancer	6.67e-05	0.000286	CcSEcCtD
Zoledronate—Headache—Doxorubicin—uterine cancer	6.63e-05	0.000285	CcSEcCtD
Zoledronate—Nausea—Doxorubicin—uterine cancer	6.29e-05	0.00027	CcSEcCtD
